September 14, 2011
As GOP presidential candidates tussle over the latest issue to split the field — oddly enough, it's the rather obscure question of whether states should mandate vaccinating girls against a sexually transmitted virus — it's hard to tell which one ends up looking worst. But our vote goes to Minnesota Rep. Michele Bachmann, whose rumor-mongering rampage against a safe and effective vaccine could discourage parents from protecting their daughters against cancer. During Monday's debate, Bachmann and former Sen. Rick Santorum lashed out at Texas Gov. Rick Perry over his 2007 executive order that Texas schoolgirls had to be vaccinated against human papillomavirus (the order was later overturned by the state legislature)
October 16, 2012 |
Wow. Can you believe it? Tetanus vaccinations do not make children likelier to walk barefoot on rusty nails. Masturbation does not cause blindness or hairy palms. And girls who get the HPV vaccination to protect against the sexually transmitted human papillomavirus, the cause of 70% of cervical cancer, do not turn slutty because of it. For this we actually had a study -- a sober, clinical response to the notional premise afoot in segments of American politics and culture that the vaccine, which can give young girls a lifetime's protection from cervical cancer, loosens their morals.
September 13, 2011 |
A 2007 executive order by Texas Gov. Rick Perry has become the latest post-debate headache for the Republican presidential front-runner, who was accused of "crony capitalism" Tuesday by Rep. Michele Bachmann. The fight over requiring vaccinations for young girls — which surfaced in Monday's Florida debate — involved government prerogatives and cancer. But it also had a strong moral subtext: Bachmann and other social conservatives objected to forcible inoculations against a disease spread by sexual activity, while Perry defended himself with the language of the antiabortion movement.
September 13, 2011 |
The HPV vaccine, which protects women against the human papilloma virus, is in the news once again, thanks to the recent GOP debate in which presidential candidate Michele Bachmann criticized Texas Gov. Rick Perry's proposed mandate of the vaccine and called it "...what potentially could be a very dangerous drug. " But that's not how most mainstream medical organizations in the U.S. see the HPV vaccine, approved in 2006 to prevent the spread of the virus, which can cause genital warts and may lead to cervical cancer.
January 5, 2012 |
Some girls may be more likely to overestimate the protection they receive from the HPV vaccine, new research shows. Human papillomaviris, the most common sexually transmitted infection, can infect the genital areas of men and women, cause genital warts and raise the risk of cervical cancer. The new study, published this week by the Archives of Pediatrics and Adolescent Medicine, looked at the perception of HPV risk among a population of 339 girls between age 13 and 21. At an average age of 16.8 years, 57.5% of these girls were sexually experienced, and most of them reported "continued need" to practice safe sex. However, a good 23.6% appeared to believe mistakenly that their risk of other sexually transmitted diseases was also lower -- even though the HPV vaccine does not protect against the rest of the pantheon of such diseases, such as HIV/AIDS, gonorrhea and syphilis.
October 15, 2012 |
A shot that would make girls more inclined to have sex. When the HPV vaccine came on the scene, there were some who had that fear: This shot will reduce worries about a harmful sexually transmitted infection -- and reduce girls' inhibitions as well. And girls could mistakenly believe it's a magic bullet against pregnancy and other sexually transmitted diseases too. A new study kicks those fears to the curb. Researchers looked at girls who'd had an HPV vaccine and tracked the appointments they made and the advice they sought regarding sexual health over the next three years.
March 18, 2013 |
Parents forgo vaccines for their teenage kids for a number of reasons, researchers said Monday in a paper reporting findings from the annual National Immunization Survey of Teens, which was published in the journal Pediatrics. That might mean that public health agencies need to try new things to get immunizations on target to prevent spread of the human papilloma virus, the cause of cervical and other cancers. Overall, immunization rates among teenagers are on the way up, the Pediatrics study noted.
October 25, 2011 |
A vaccine that protects against the sexually transmitted human papillomavirus should be routinely given to boys ages 11 and 12 to prevent anal cancer, a government advisory committee has decided. Though many parents may not wish to contemplate the future sex lives of their pre-adolescent children, vaccinating them young is the best way to avoid the risk of the cancer-causing virus, experts said Tuesday. The recommendation is sure to ignite further debate among the Republican presidential candidates who have focused intently on whether the controversial vaccine, called Gardasil, is appropriate for girls — who receive it for prevention of cervical cancer — let alone for boys.
June 19, 2006 |
On June 8, the Food and Drug Administration approved the first vaccine to lower a woman's risk of developing cervical cancer. The vaccine, Gardasil, prevents infection by four strains of human papillomavirus, a common sexually transmitted disease. The vaccine was approved for use in girls and women ages 9 to 26. For women older than 26, Pap smears remain necessary to guard against cervical cancer. Shari Roan ** Three-quarters of all U.S.
January 27, 2012 |
A new study showing an estimated 7% of American teens and adults carry the human papillomavirus in their mouths may help health experts finally understand why rates of mouth and throat cancer have been climbing for nearly 25 years. The evidence makes it clear that oral sex practices play a key role in transmission. The new data, published online Thursday by the Journal of the American Medical Assn., are the first to assess the prevalence of oral HPV infection in the U.S. population.